Ascentgene Inc.

Gaithersburg, MD

UEI
FFJZXSPAFDL3
CAGE
559V9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Asian-Pacific American Owned
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
900 Clopper Rd #130, Gaithersburg, MD 20878, USA
Website
ascentgene.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Production of 3 CHO cell lines HHSF223201300405A Food and Drug Administration $22,410
Sbir topic 256 - innovative methods for manufacturing safe, efective cancer therapeutics HHSN261200900031C National Cancer Institute (NIH) $219,821
TET-on shrna stable cell line service HEK 293) for high complex microbiology service HHSN275200900295P National Institute of Child Health and Human Development (NIH) $6,885

Similar vendors

Vendor Location Primary NAICS
Meganano Biotech Inc. UEI NDFZN2D9CNJ9 Tampa, FL 541714 Research and Development in Biotechnology (except Nanobiotechnology)

See more similar vendors on GovTribe

SBA capabilities narrative

From the vendor's SBA profile

1. manufacture of recombinant proteins, monoclonal antibodies, virus-like particles for research and drug development

2. cell line development for research and therapeutic purposes

Quick answers

Is Ascentgene Inc. registered in SAM.gov?

Yes. Ascentgene Inc.'s SAM.gov registration is active through August 3, 2027.

What is Ascentgene Inc.'s most recent federal award?

Ascentgene Inc.'s most recent federal contract award is Production of 3 CHO cell lines (HHSF223201300405A), from Food and Drug Administration, on September 4, 2013.

On GovTribe

See Ascentgene Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login